Vilmorin & Cie SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vilmorin & Cie SA Receives Authorization for Joint Venture from European Commission.
Vilmorin & Cie SA announced that, alongside KWS, it has obtained authorization from the European Commission for their 50/50 joint venture Genective, which develops GM traits for corn seed
- Share this
- Digg this